Quest for the right Drug
קוסופט COSOPT (DORZOLAMIDE AS HYDROCHLORIDE, TIMOLOL AS MALEATE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
עיני : OCULAR
צורת מינון:
תמיסה לעין : EYE DROPS, SOLUTION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects In clinical studies for COSOPT the observed adverse reactions have been consistent with those that were reported previously with dorzolamide hydrochloride and/or timolol maleate. During clinical studies, 1035 patients were treated with COSOPT. Approximately 2.4% of all patients discontinued therapy with this medicinal product because of local ocular adverse reactions, approximately 1.2% of all patients discontinued because of local adverse reactions suggestive of allergy or hypersensitivity (such as lid inflammation and conjunctivitis). Like other topically applied ophthalmic medicines, timolol is absorbed into the systemic circulation. This may cause similar undesirable effects as seen with systemic beta-blocking agents. Incidence of systemic ADRs after topical ophthalmic administration is lower than for systemic administration. The following adverse reactions have been reported with COSOPT or one of its components either during clinical trials or during post-marketing experience: [Very Common: (≥1/10), Common: (≥1/100 to <1/10), Uncommon: (≥1/1,000 to <1/100), and Rare: (≥1/10,000 to <1/1,000), Not known (cannot be estimated from the available data)] System Organ Formulation Very Common Uncommon Rare Not Known** Class Common (MedDRA) Immune system COSOPT signs and disorders symptoms of systemic allergic reactions, including angioedema, urticaria, pruritus, rash, anaphylaxis Timolol signs and pruritus maleate eye symptoms of drops, solution allergic reactions including angioedema, urticaria, localized and generalized rash, anaphylaxis Metabolism and Timolol hypoglycaemia nutrition maleate eye disorders drops, solution Psychiatric Timolol depression* insomnia*, hallucination disorders maleate eye nightmares*, drops, solution memory loss Nervous system Dorzolamide headache* dizziness*, disorders hydrochloride paraesthesia* eye drops, solution Timolol headache* dizziness*, paraesthesia*, maleate eye syncope* increase in drops, solution signs and symptoms of myasthenia gravis, decreased libido*, cerebrovascular accident*, cerebral ischaemia Eye disorders COSOPT burning and conjunctival stinging injection, blurred vision, corneal erosion, ocular itching, tearing Dorzolamide eyelid iridocyclitis* irritation Foreign body hydrochloride inflammation including sensation in eye eye drops, *, eyelid redness*, solution irritation* pain*, eyelid crusting*, transient myopia (which resolved upon discontinuation of therapy), corneal oedema*, ocular hypotony*, choroidal detachment (following filtration surgery)* Timolol signs and visual ptosis, itching, tearing, maleate eye symptoms of disturbances diplopia, redness, blurred drops, solution ocular including choroidal vision, corneal irritation refractive detachment erosion including changes (due following blepharitis*, to withdrawal filtration keratitis*, of miotic surgery* (see decreased therapy in Special corneal some cases)* warning and sensitivity, precautions for and dry eyes* use 4.4) Ear and Timolol tinnitus* labyrinth maleate eye disorders drops, solution Cardiac Timolol bradycardia* chest pain*, atrioventricular disorders maleate eye palpitation*, block, cardiac drops, solution oedema*, failure arrhythmia*, congestive heart failure*, cardiac arrest*, heart block Dorzolamine Palpitations hydrochloride eye drops, solution Vascular Timolol hypotension*, disorders maleate eye claudication, drops, solution Raynaud’s phenomenon*, cold hands and feet* Respiratory, COSOPT sinusitis shortness of thoracic, and breath, mediastinal respiratory failure, disorders rhinitis, rarely bronchospasm Dorzolamide epistaxis* dyspnoea hydrochloride eye drops, solution Timolol dyspnoea* bronchospasm maleate eye (predominantly drops, solution in patients with pre-existing bronchospastic disease)*, respiratory failure, cough* Gastrointestinal COSOPT dysgeusia disorders Dorzolamide nausea* throat hydrochloride irritation, dry eye drops, mouth* solution Timolol nausea*, diarrhoea, dysgeusia, maleate eye dyspepsia* dry mouth* abdominal pain, drops, solution vomiting Skin and COSOPT contact subcutaneous dermatitis, tissue disorders Stevens- Johnson syndrome, toxic epidermal necrolysis Dorzolamide rash* hydrochloride eye drops, solution Timolol alopecia*, skin rash maleate eye psoriasiform drops, solution rash or exacerbation of psoriasis* Musculoskeletal Timolol systemic lupus myalgia and connective maleate eye erythematosus tissue disorders drops, solution Renal and COSOPT urolithiasis urinary disorders Reproductive Timolol Peyronie’s sexual system and maleate eye disease*, dysfunction breast disorders drops, solution decreased libido General Dorzolamide asthenia/ disorders and Hydrochloride fatigue* administration eye drops, site conditions solution Timolol asthenia/ maleate eye fatigue* drops, solution *These adverse reactions were also observed with COSOPT during post-marketing experience. **Additional adverse reactions have been seen with ophthalmic beta-blockers and may potentially occur with COSOPT. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form https://sideeffects.health.gov.il
מסגרת הכללה בסל
התוויות הכלולות במסגרת הסל
התוויה | תאריך הכללה | תחום קליני | Class Effect | מצב מחלה |
---|---|---|---|---|
DORZOLAMIDE | ||||
TIMOLOL |
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
01/03/2002
הגבלות
תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת
מידע נוסף